Public Plan Would Improve Market, Sebelius Testifies At House Committee
This article was originally published in The Pink Sheet Daily
HHS secretary endorses the principles behind the House discussion draft on health care reform during a June 24 hearing; Sebelius’ statements on public option echo President Obama’s press conference from the day before.
You may also be interested in...
The Senate Health, Education, Labor and Pensions Committee's health care reform bill is headed to markup beginning June 16, although details of key provisions, including establishment of a public insurance option, are still being developed
Bipartisan congressional letters seek relief from HHS but the Trump Administration has taken aim at 340B providers itself and may not be inclined to help.
Value-based contracting in the US is moving toward high-cost drugs for rare disease and away from lower cost chronic treatments as payers plan for the coming pipeline of cell and gene therapies. Marketed gene therapies all have some kind of risk sharing deal in place but further progress on the most innovative payment models is hampered by regulatory and operational challenges. The Centers for Medicare and Medicaid Services has taken a first step toward addressing regulatory obstacles but there is a long way to go.